Leading in MPNs Beyond Ruxolitinib in Combo With T-Regs
Clinical trial NCT05423691 · RECRUITING
Trial details
- NCT number
- NCT05423691
- Sponsor
- Cellenkos, Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-27
- Primary completion
- 2026-04-30
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.